0001104659-24-060005.txt : 20240510 0001104659-24-060005.hdr.sgml : 20240510 20240510172431 ACCESSION NUMBER: 0001104659-24-060005 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240508 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 24936114 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 8-K/A 1 tm2414175d2_8ka.htm FORM 8-K/A
true On May 8, 2024, Accelerate Diagnostics, Inc. (the "Company") issued a press release announcing its preliminary financial results for the quarter ending March 31, 2024, which was included as Exhibit 99.1 to a Current Report on Form 8-K (the "Original Report") furnished with the U.S. Securities and Exchange Commission (the "SEC") on such date. This Current Report on Form 8-K/A (this "Report") is being filed to disclose certain updates to the Company's financial results for the quarter ending March 31, 2024 included in the Original Report as described in Item 2.02 to this Report below. 0000727207 0000727207 2024-05-08 2024-05-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

(Amendment No. 1)

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 8, 2024

 

Accelerate Diagnostics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-31822   84-1072256
(Commission File Number)   (IRS Employer Identification No.)

 

3950 South Country Club Road, Suite 470, Tucson, Arizona   85714
(Address of principal executive offices)   (Zip Code)

 

(520) 365-3100

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol Name of each exchange on which
registered
Common Stock, $0.001 par value per share AXDX

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

EXPLANATORY NOTE

 

On May 8, 2024, Accelerate Diagnostics, Inc. (the “Company”) issued a press release announcing its preliminary financial results for the quarter ending March 31, 2024, which was included as Exhibit 99.1 to a Current Report on Form 8-K (the “Original Report”) furnished with the U.S. Securities and Exchange Commission (the “SEC”) on such date. This Current Report on Form 8-K/A (this “Report”) is being filed to disclose certain updates to the Company’s financial results for the quarter ending March 31, 2024 included in the Original Report as described in Item 2.02 to this Report below.

 

Item 2.02.Results of Operations and Financial Condition.

 

On May 8, 2024, the Company issued a press release announcing its preliminary financial results for the quarter ending March 31, 2024. Subsequently, in connection with the finalization of its financial statements for the quarter ending March 31, 2024, the Company made certain non-cash related revisions to the accounting for its previously announced January 2024 equity financing. The revisions resulted in, among other things, a decrease in the Company’s net loss and net loss per share from $17.0 million and $0.88, respectively, as preliminarily reported in the Original Report, to $14.2 million and $0.74, respectively.

 

The revisions are reflected in the updated financial tables attached hereto as Exhibit 99.1, which is incorporated herein by reference in its entirety. The revisions are also reflected in the condensed consolidated financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, which will be filed with the SEC on or around the date hereof.

 

In accordance with General Instruction B.2 for Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits.

 

Exhibit  
Number Description
99.1 Updated Financial Tables Reflecting Revisions to Previously Reported Preliminary Financial Results for the Quarter Ending March 31, 2024
104 Cover Page Interactive Data File (cover page XBRL tags are embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  ACCELERATE DIAGNOSTICS, INC.
  (Registrant)
 Date: May 10, 2024  
  /s/ David Patience
  David Patience
  Chief Financial Officer

 

 

 EX-99.1 2 tm2414175d2_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

ACCELERATE DIAGNOSTICS, INC.

CONDENSED CONSOLIDATED

BALANCE SHEETS

Unaudited

(in thousands, except share data)

 

   March 31,   December 31, 
   2024   2023 
ASSETS
Current assets:          
Cash and cash equivalents  $14,606   $12,138 
Investments   1,145    1,081 
Trade accounts receivable   2,217    2,622 
Inventory   3,249    3,310 
Prepaid expenses   1,068    380 
Purchase obligation put option asset   —    3,419 
Other current assets   1,848    1,516 
Total current assets   24,133    24,466 
Property and equipment, net   3,197    2,389 
Finance lease assets, net   1,225    1,518 
Operating lease right of use assets, net   957    1,177 
Other non-current assets   1,210    1,816 
Total assets  $30,722   $31,366 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:          
Accounts payable  $5,108   $4,796 
Accrued liabilities   3,351    3,243 
Accrued interest   1,014    164 
Deferred revenue and income, current   1,272    1,545 
Current portion of convertible notes   726    726 
Common warrant liability   3,035    — 
Finance lease, current   685    583 
Operating lease, current   940    977 
Total current liabilities   16,131    12,034 
Finance lease, non-current   81    262 
Operating lease, non-current   328    570 
Deferred income, non-current   1,110    1,122 
Other non-current liabilities   1,197    1,164 
Convertible notes, non-current   37,655    36,102 
Total liabilities  $56,502   $51,254 
           
Commitments and contingencies          
           
Stockholders’ deficit:          
Preferred shares, $0.001 par value;          
5,000,000 preferred shares authorized and no shares issued or outstanding as of March 31, 2024 and December 31, 2023   —    — 
Common stock, $0.001 par value;          
450,000,000 common shares authorized with 21,811,706 shares issued and outstanding on March 31, 2024 and 14,569,500 shares issued and outstanding on December 31, 2023   21    14 
Contributed capital   702,971    694,634 
Treasury stock   (45,067)   (45,067)
Accumulated deficit   (683,087)   (668,857)
Accumulated other comprehensive loss   (618)   (612)
Total stockholders’ deficit   (25,780)   (19,888)
Total liabilities and stockholders’ deficit  $30,722   $31,366 

 

 

 

 

ACCELERATE DIAGNOSTICS, INC.

CONDENSED CONSOLIDATED

STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

Unaudited

(in thousands, except per share data)

   Three Months Ended 
   March 31,   March 31, 
   2024   2023 
Net sales  $2,921   $2,812 
           
Cost of sales   2,198    1,801 
Gross profit   723    1,011 
           
Costs and expenses:          
Research and development   5,173    6,968 
Sales, general and administrative   5,706    10,105 
Total costs and expenses   10,879    17,073 
           
Loss from operations   (10,156)   (16,062)
           
Other income (expense):          
Interest expense   (2,450)   (418)
Interest expense related party   —    (1,013)
Loss on fair value instruments   (1,216)   — 
Foreign currency exchange gain   19    233 
Interest income   200    420 
Other (expense) income, net   (627)   45 
Total other expense, net   (4,074)   (733)
           
Net loss before income taxes   (14,230)   (16,795)
Provision for income taxes   —    — 
Net loss  $(14,230)  $(16,795)
           
Basic and diluted net loss per share  $(0.74)  $(1.71)
Weighted average shares outstanding   19,216    9,830 
           
Other comprehensive loss:          
Net loss  $(14,230)  $(16,795)
Net unrealized loss on debt securities available-for-sale   —    24 
Foreign currency translation adjustment   (6)   (255)
Comprehensive loss  $(14,236)  $(17,026)

 

 

 

 

ACCELERATE DIAGNOSTICS, INC.

CONDENSED CONSOLIDATED

STATEMENTS OF CASH FLOWS

Unaudited

(in thousands)

 

   Three Months Ended 
   March 31,   March 31, 
   2024   2023 
Cash flows from operating activities:          
Net loss   (14,230)   (16,795)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   858    802 
Provision for bad debts   19    — 
Equity-based compensation   1,297    555 
Amortization of debt discount and issuance costs   1,596    182 
Amortization of debt discount related-party   —    572 
Loss on disposal of property and equipment   71    11 
Unrealized gain on equity investments   (53)   (50)
Units offering issuance cost   680    — 
Loss on fair value adjustments   1,216    — 
(Increase) decrease in assets:          
Contributions to deferred compensation plan   (11)   — 
Accounts receivable   386    (11)
Inventory   (85)   (140)
Prepaid expense and other   (448)   (239)
Increase (decrease) in liabilities:          
Accounts payable   312    (977)
Accrued liabilities and other   (658)   1,945 
Accrued interest   850    235 
Accrued interest due to related-party   —    441 
Deferred revenue and income   (285)   (79)
Deferred compensation   33    181 
Net cash used in operating activities   (8,452)   (13,367)
           
Cash flows from investing activities:          
Purchases of equipment   (513)   (12)
Maturities of marketable securities   —    8,221 
Net cash (used in) provided by investing activities   (513)   8,209 
           
Cash flows from financing activities:          
Proceeds from issuance of Units to related party   2,050    — 
Proceeds from issuance of Units   10,232    — 
Units offering issuance cost   (764)   — 
Payments on finance leases   (79)   (77)
Net cash provided by financing activities   11,439    (77)
           
Effect of exchange rate on cash   (6)   (262)
           
(Decrease) increase in cash and cash equivalents   2,468    (5,497)
Cash and cash equivalents, beginning of period   12,138    34,905 
Cash and cash equivalents, end of period  $14,606   $29,408 

 

 

 

 

ACCELERATE DIAGNOSTICS, INC.

CONDENSED CONSOLIDATED

STATEMENTS OF CASH FLOWS (CONTINUED)

Unaudited

(in thousands)

 

   Three Months Ended 
   March 31,   March 31, 
   2024   2023 
Non-cash investing activities:          
Net transfer of instruments from inventory to property and equipment  $127   $71 
Non-cash financing activities:          

Net transfer of instruments from inventory to property and equipment

  $43   $0 
Accrued units offering issuance cost  $473   $0 
Supplemental cash flow information:          
Interest paid  $10   $0 

 

See accompanying notes to condensed consolidated financial statements.

 

 

 

 

 

 EX-101.SCH 3 axdx-20240508.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 axdx-20240508_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 axdx-20240508_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
May 08, 2024
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description On May 8, 2024, Accelerate Diagnostics, Inc. (the "Company") issued a press release announcing its preliminary financial results for the quarter ending March 31, 2024, which was included as Exhibit 99.1 to a Current Report on Form 8-K (the "Original Report") furnished with the U.S. Securities and Exchange Commission (the "SEC") on such date. This Current Report on Form 8-K/A (this "Report") is being filed to disclose certain updates to the Company's financial results for the quarter ending March 31, 2024 included in the Original Report as described in Item 2.02 to this Report below.
Document Period End Date May 08, 2024
Entity File Number 001-31822
Entity Registrant Name Accelerate Diagnostics, Inc.
Entity Central Index Key 0000727207
Entity Tax Identification Number 84-1072256
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 3950 South Country Club Road
Entity Address, Address Line Two Suite 470
Entity Address, City or Town Tucson
Entity Address, State or Province AZ
Entity Address, Postal Zip Code 85714
City Area Code 520
Local Phone Number 365-3100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol AXDX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://acceleratediagnostics.com/role/Cover Cover Cover 1 false false All Reports Book All Reports axdx-20240508.xsd axdx-20240508_lab.xml axdx-20240508_pre.xml tm2414175d2_8ka.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2414175d2_8ka.htm": { "nsprefix": "axdx", "nsuri": "http://acceleratediagnostics.com/20240508", "dts": { "schema": { "local": [ "axdx-20240508.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "axdx-20240508_lab.xml" ] }, "presentationLink": { "local": [ "axdx-20240508_pre.xml" ] }, "inline": { "local": [ "tm2414175d2_8ka.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://acceleratediagnostics.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2414175d2_8ka.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2414175d2_8ka.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://acceleratediagnostics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-060005-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-060005-xbrl.zip M4$L#!!0 ( ^+JEAL9H$(,P, H, 1 87AD>"TR,#(T,#4P."YX M],_T'U:\:82VB 0#(I:3I,2=.!YM*\=(2\@"9"/L&F:?YSG71#07F-]"U(&Z'#\4Y^H(GT$"?@(/$6LAS](!9:"WBAC*0 MJ"TF 0,-9B/QU$#50KD\0*Z[A^X#<%_(^UYGKCO6.E -SYM.IP4N7O%4R!=5 M(&*RGV!?8QVJN5HQ*J;/?O1;JLB?1L!K81=7GLDC_GS[.+CS M?SWW3F;?7R(]^5 ;##D^FWUD)Z7.Z;A=>YK55;GCJ[O$95.1,4PP,L7@JN78 M_-+TII6"D".O7"R6O*?;;C_&.0FP$3'*7S;!2_5ZW8MW,V@.&0TDRZ0KGMT> M8 5S9;-+=^ I5QISLH+W]9RP#*YZR>8*E&Z$OD^@-(/ZL(930 HC\>J9#8,O M5S)@J-P1QL$:(SK(%?/ E ;HHI9P6J\6:&3,&$^#Z1LC)-0QQR$Q4/T/,Z)""[R"-Y0BT[3@5 M8 *'2&<]C#D7IM7-O*46:PL":GIY;C F6_N&% R^F:2079A9V\.?17IM82X/ M!U&_Y23+)>5,VX*53@W_&+>!U(4(8> MY]\2(B "DIJ;MERZ+ M)'2J+?WKDAMD_2@'>?\PFMCIEY7Q_%IDE72(UX M;L!W7;;)9Z(K2"RU@V+?W(SG6I-;*KN54B%2_B+20X)8G,!A062\(X+8W"ME!E7Z=;/AT[G6[D>,"TRBQ'A[#\H?F+&&*9@X)8*:>OI6&1X M+3(P,C0P-3 X7VQA8BYX;6S-G5UOX[@5AN\+]#]PW9L6&,<3!RV0[&07&4^R M,#:;9&//;-M%L: EQA%"DP$E)_:_+RF)LD3Q2$J*DIR+&8_X'NJE^)BDOHX_ M_;C;4/1"1)IP=CXZ/OHX0H1%/$[8^GST=3&^6,SF\Q%*,\QB3#DCYR/&1S_^ M\.<_(?GGTW?C,;I*"(W/T!<>C>?L@7^/;O"&G*&?"","9UQ\C[YANE5;^%5" MB4 SOGFF)".RH-CQ&?K[T72Z0N/Q@'J_$19S\?5^7M7[F&7/Z=ED\OKZ>L3X M"W[EXBD]BOAF6(6+#&?;M*KMX^YC^:<(_T03]G2F_EKAE"!YO%AZMDN3\Y': M;[G;UY,C+M:3Z<>/QY-__G*]B![)!H\3IHY;1$8Z2M5BBSL^/3V=Y*5:VE+N M5H+J?9Q,M)VJ9EF:=.AK3M+D+,WM7?,(9WFW]^X&@0KUO[&6C=6F\?%T?')\ MM$OCD3[X^1$4G))[\H#R9IYE^V>)4IHH$D;EMD=!'NQFJ! 3%3]A9(TS$JL= MG:H='?]#[>@OY>9KO")TA)12\@&VZ[115QDT<6WVCHB$QY?L?:[-:$_VY7=' M9/]# ^KQSINPY!FF[S)?CW1N^X:\[X@?XMP?:3G.D_<=Z5KD_\5VUK;\YL-K M/ZY4;;R6GQH6R2Z3$QB)M4E51<<(G.\AGQC*NJO:>=2HEZK1G(MVV]7,F->9 MDNAHS5\F,4EDW=,3]6&L/N3-EO_Y8\;E2N!BE68"1YFN*6_&^6% MT+ZPB'H:5RHF$9=3TW,VIL5A+,(?!-]8=UNVFEL*_Z"K*KXX+'(7@-&&3)"4 M;T5$WM0K=;?042H=;:A4J"458>.OB]$/N0;]KE7_^30YU.*@H^42:+LA+%O* M&BTM:!:[ZF:;*=W+];(@.MEBR.QC+4%*X[B#+^2.8[7S*XK7%OM&N:LNMMK2 M?=PH#**3;8[,7JXT2(E\=?,7DD8B>5;+^:YV-&3..]UBLM7W-4U8"+2-P234 MM)X&]GNR3M34HBRH\UNB-G8,8X#>]=#?:=N<"ZSB(* 9XA"<+>I!J(KRQ-$% M8UM,[\DS%UWX-&6NJ;&9-&&I:X)BQ&(,1*/0HD+LB8A?M_*,G0BZ[X6BI73- M!6#51,.0!46'W1L(2"7WR\A28)8F:@#KA:0M=7ZZ 9AMG7H8NJ X )2B .%H.NM#0ZI]@G&5I!&FA99?!(MAN-24?F!I6;6C4LD"!,7TUH>) MTGN!9+85HN$:GG%@J;.;LCUFJ_NS@"X(4'K,M>[:%O(&*)YFH$N6)=E>/4]W ML]VLB+ TKBUQQ09D3C-AE@?! F#*9*"0(:5#A=!+S^N[!"Q3#S&"S3%E;@FP MFVQ2T-0$1(+5&$##09L_4^J%B)D,'(/MMVK=TM5AM\F411@02; [@)]2^4%_0"H&W;)0H)F^ MH:E3_]!,AT(S#1J:Z7N@6;[R0* Y>4-33_Q#+BTO/7!H@+4>D:%^,0D7UC=BCO!7Q(6P4MF M2.X%&,"TE1I#&QXZ=H-]_%0+8AWG=:PI%N6]7Q(M\S/*-$W:AYA"$QXD36.] M@TNA]HG$'4\S3/^=/'>>B-O%7O"P&K9"TE"&AXK-7A\P10R203Y.K$MYFQ:@@&!@1FL7..MEBJNKC M6ED87=PVU.KA_'LM-3Z^R"J["[U[Y Q^0* M<=73D#G=VV9Y$#T.F#)[/9>A M7.?I:KS*,)':A^]:F;.9W;133>2Z((C>-=VTIFE=[K@W?Q-))O<\XYO-EI5W M>6S/#0(Z5[W<:5/WN%441.]W.3-)*+6H*7:,Q8+3)$JRA*U_D2>?(L&V5ME$ MKH" #6H:VHH@4 !MF1P(/Z'CZ MU]7?D(YRW/TW?"FP2AZ[V&]6G +9IZPJ5Q!T6-0<6"1!H #[,FFXX:B4HD+K M(SM5PZRE.4:Y*P"LMG37-PJ#Z'2;H]:7O]'7GH;\RUWT*$T1X(4$N\SUT&\S M:0[_=4T0"'08:YV4E%*DM3Y>2#A,6>O^1<#:VR)@W;,(6(>X"%@/702LO2T" M]&Z+%"%R7+I=T62-@>2$G6K74'18-OFP2(-"!?8'CAE5"#K$N,YHF:V%Y*Y?JNPR;;Y-:=,&A%"G0?#]R2I&I8K!FBEO*6/$3"ZUUKSC*7%# MY3YQ3,MB.W=,)0D(#YNOC@PR FFM%Q86&TSIYVV:,)+"$Y&AEYN89V0#ONW0'^**H*'F-4=]^B!H&FC29"H/ M:YY48OLK2T#C.F->V9R3+.P@"(J#M"DJ1EPM1KO32_Y\Q>Q+;YRS:WPD>$:*> MLDJKT:KO^MO :+?,O*E)39H&A0;$V5O\ @0>JD"U.C[49BR?%_/40^,JFQN/ MGA:/6![ VVV6JAE4&H.O@G<&.;Z],* !QDV&CHB T!M@$[KAD$>B//0#*H)1 M+=K3^5EZR )(XL_[>_) A'KO8$EVV6>YHZ>.,XP!L:[/W@8WQSR9ZPT, L*W MNH5.]5)4KP"MU#-B917H=U4)RFNQ_7YY?=.U_"0WZTWRKQ5.B=SR7U!+ P04 M " /BZI8@3%C+6(' #O5P %0 &%X9'@M,C R-# U,#A?<')E+GAM M;,V<37/;-A"&[YWI?V#5LRQ+:MK8L9MQ%"NCB1.[EI.TO60@$I(P!@$- %K2 MOR] BHH^"'#= ]<^V#*U /9]%@2Y!,"+MZN41T]4:2;%9:M[C(:,\.8_>R[@]$E/Y M)OI,4GH>?:""*F*D>A-])3QS1^20<:JB@4P7G!IJOR@:/H]>G?1ZDZC=!M3[ ME8I$JB_WHVV]Z=U.Z]CKNCTLD56R,\5[F(C#W27_3R/@*;QR4P^=1+*;"1Z???!0>GG0.P_W_.& MKB;:*!*;LB9.)I3G]7^W-@*M\*;0UC+L^=>SICSE_GBKL0 M4W

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end XML 17 tm2414175d2_8ka_htm.xml IDEA: XBRL DOCUMENT 0000727207 2024-05-08 2024-05-08 iso4217:USD shares iso4217:USD shares true On May 8, 2024, Accelerate Diagnostics, Inc. (the "Company") issued a press release announcing its preliminary financial results for the quarter ending March 31, 2024, which was included as Exhibit 99.1 to a Current Report on Form 8-K (the "Original Report") furnished with the U.S. Securities and Exchange Commission (the "SEC") on such date. This Current Report on Form 8-K/A (this "Report") is being filed to disclose certain updates to the Company's financial results for the quarter ending March 31, 2024 included in the Original Report as described in Item 2.02 to this Report below. 0000727207 8-K/A 2024-05-08 Accelerate Diagnostics, Inc. DE 001-31822 84-1072256 3950 South Country Club Road Suite 470 Tucson AZ 85714 520 365-3100 false false false false Common Stock, $0.001 par value per share AXDX NASDAQ false